BCNatal's fetaLife project for extremely premature babies achieves a 21-day survival in a liquid incubator
After more than five years of work, the scientific team behind the fetaLife project for extremely preterm infants has developed a functional prototype of an artificial placenta, or liquid incubator, which has achieved 21 days of survival in good condition in an experimental sheep model and more than 13 months of postnatal survival once off the device with good neurodevelopmental outcomes.
-
Sant Joan de Déu, the first Spanish hospital to produce advanced therapies for public and private institutions in Europe
The Advanced Therapies Platform of Sant Joan de Déu has received MIA accreditation, which allows the center to operate with the status of a pharmaceutical laboratory, producing and exporting advanced therapies to other centers and institutions.
-
Eliminating language barriers is key to ensuring that pediatric patients can access and participate in clinical trials beyond their country of origin
The study shows that language barriers can limit children's and young people's access to international clinical trials and calls for measures to ensure equity in pediatric research.
-
Psychosis research reaches educational centers
The Patient Engagement in Research Area of the Institut de Recerca Sant Joan de Déu (IRSJD) has launched an educational initiative aimed at 3rd and 4th year ESO students to address mental health, contribute to the reduction of prejudices and stigmas, and promote the recognition of risk factors associated with psychotic disorders, also promoting early detection and prevention in the face of any warning signs.
-
Bellvitge and Sant Joan de Déu identify the genetic variants associated with the most severe forms of Stargardt’s disease
Stargardt's disease is a rare disease that causes the loss of central vision, progressively and irreversibly. It is usually diagnosed before the age of 20 and it is very difficult to predict the evolution of patients: some may worsen very quickly while in others the disease progresses slowly.
-
An international study led by Sant Joan de Déu confirms that GNAO1-RD disease is not degenerative
The study describes for the first time the long-term evolution of disorders related to the GNAO1 gene.
-
Joan Comella will take over the management of the Fundació Sant Joan de Déu, replacing Emili Bargalló
Today, April 29, the leadership transition at the Fundació Sant Joan de Déu (FSJD) becomes effective. In this new stage, Joan Comella takes over the leadership from Emili Bargalló, who concludes a 15-year period leading the institution.
-
Consuming ultra-processed foods during pregnancy is associated with more than double the risk of developing preeclampsia
Higher consumption of ultra-processed foods during pregnancy is associated with more than double the risk of preeclampsia, a serious but preventable complication.
-
Dr. Joan Comella Carnicé, director of the Institut de Recerca Sant Joan de Déu, is appointed Full Member of the Reial Acadèmia de Medicina de Catalunya
The director of the Institut de Recerca Sant Joan de Déu (IRSJD) has been appointed Full Member of the Reial Acadèmia de Medicina de Catalunya (RAMC), a recognition that highlights his scientific career and his contribution to the advancement of medicine and biomedical research.
